Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03721367 · ClinicalTrials.gov registry record
Chronic Liver Disease in Urea Cycle Disorders
A clinical trial, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- 28
- Enrollment target
NCT03721367: Completed study, sponsored by Baylor College of Medicine.
NCT03721367 is a clinical trial that has completed, run by Baylor College of Medicine. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03721367 has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
This is a pilot, cross-sectional study to assess liver stiffness and markers of hepatic injury, function, and fibrosis in patients with urea cycle disorders. This study will be conducted at 3 UCDC sites: Baylor College of Medicine in Houston, Texas, University of California San Francisco (UCSF), San Francisco, California and Seattle Children's Hospital, Seattle,Washington
Primary Outcome
Shear wave elastography in m/s is a measure of liver stiffness, a surrogate measure for hepatic fibrosis. Normal liverstiffness is \< 1.35 m/s and abnormal liver stiffness is \>1.35 m/s
Interventions
- OTHER Diagnostic Ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2017-11-29 |
| Est. Completion | 2020-06-01 |
What the finished NCT03721367 record still lists
NCT03721367 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 28 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Diagnostic Ultrasound is the first listed.
NCT03721367 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03721367 about?
NCT03721367 is a clinical study titled "Chronic Liver Disease in Urea Cycle Disorders". This is a pilot, cross-sectional study to assess liver stiffness and markers of hepatic injury, function, and fibrosis in patients with urea cycle disorders. This study will be conducted at 3 UCDC sites: Baylor College of Medicine in Houston, Texas, University of California San Francisco (UCSF), San...
What is the current status of trial NCT03721367?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2017-11-29. Estimated completion is 2020-06-01.
What interventions are being tested in trial NCT03721367?
The interventions under investigation include: Diagnostic Ultrasound (OTHER).
Who is sponsoring clinical trial NCT03721367?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI